JMI Specialized Hospital to become public limited company

JMI Hospital Requisite Manufacturing Ltd has announced the conversion of JMI Specialized Hospital Limited (JSHL), a subsidiary, into a public limited company.

The decision was taken at a board meeting on December 2, according to a disclosure on the Dhaka Stock Exchange (DSE) website today.

Its board noted that the company has invested an additional Tk 10.6 crore in JSHL, raising total investment to Tk 31.6 crore.

It further resolved not to invest more and to reduce its shareholding below 50 percent, thereby converting JSHL from a subsidiary to an associate while retaining significant influence.

For the July-September quarter, JMI Hospital Requisite Manufacturing reported a profit of Tk 3.59 crore, down 48 percent year‑on‑year.

The decline was attributed to lower sales and operating expenses that did not fall proportionately.

Commercial operations at JSHL also began during the quarter, leading to higher initial costs and further pressure on earnings, the company said in a price‑sensitive disclosure.

Founded in 2008 through a joint venture with South Korea, JMI Hospital Requisite Manufacturing produces IV cannulas, bulk needles, blood transfusion sets and urine drainage bags.

Its products are sold both domestically and internationally.

As of November 30, 2025, sponsors/directors held 32.30 percent shares of JMI Hospital Requisite Manufacturing, institutions 43.03 percent and public 24.67 percent, according to DSE data.